Tonix Pharmaceuticals Holding Corp (TNXP) Event Aug. 02, 2022, 11:07 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Full text
Register to leave comments News bot Oct. 2, 2025, 5:04 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update Filing Date: 2022-08-02 Accepted: 2022-08-02 07:07:00 Event Type: Clinical Trial Update Event Details: Tonix Pharmaceuticals Holding Corp (TNXP) Announces Clinical Trial Update Tonix Pharmaceuticals Holding Corp (TNXP) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update. 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: Tonix Pharmaceuticals Holding CorpCIK: 0001430306Ticker Symbol: TNXPPeriod End Date: 2022-08-02Document Type: 8-K
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update
Filing Date: 2022-08-02
Accepted: 2022-08-02 07:07:00
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: